Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 60.60
-0.20 (-0.33%)
Aug 7, 2026, 12:32 PM CET
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €974.81 million as of August 7, 2026. Its market cap has increased by 37.35% in one year.
Market Cap
974.81M
Enterprise Value
995.28M
Revenue
320.67M
Ranking
n/a
PE Ratio
21.18
Stock Price
€60.60
ChartMarket Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 974.81M, an increase of 163.80%. That is a compound annual growth rate of 5.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 974.81M | 22.49% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.10B |
| Laboratorios Farmaceuticos Rovi | 3.01B |
| Almirall | 2.39B |
| Faes Farma | 1.40B |
| Pharma Mar | 1.36B |
| Oryzon Genomics | 242.12M |
| Prim, S.A. | 227.98M |
| Laboratorio Reig Jofre | 223.88M |